ES379642A1 - Procedimiento para la obtencion de vacunas perfeccionadas. - Google Patents

Procedimiento para la obtencion de vacunas perfeccionadas.

Info

Publication number
ES379642A1
ES379642A1 ES379642A ES379642A ES379642A1 ES 379642 A1 ES379642 A1 ES 379642A1 ES 379642 A ES379642 A ES 379642A ES 379642 A ES379642 A ES 379642A ES 379642 A1 ES379642 A1 ES 379642A1
Authority
ES
Spain
Prior art keywords
deae
vaccine
adjuvant
contain
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES379642A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES379642A1 publication Critical patent/ES379642A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/815—Viral vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES379642A 1969-05-13 1970-05-13 Procedimiento para la obtencion de vacunas perfeccionadas. Expired ES379642A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1924304A DE1924304C3 (de) 1969-05-13 1969-05-13 Diäthylaminoäthyldextran (DEAE-D) als Adjuvans für Impfstoffe zur aktiven Immunisierung von Säugetieren

Publications (1)

Publication Number Publication Date
ES379642A1 true ES379642A1 (es) 1973-01-16

Family

ID=5734041

Family Applications (1)

Application Number Title Priority Date Filing Date
ES379642A Expired ES379642A1 (es) 1969-05-13 1970-05-13 Procedimiento para la obtencion de vacunas perfeccionadas.

Country Status (9)

Country Link
US (1) US3632741A (es)
JP (1) JPS4921049B1 (es)
BE (1) BE750349A (es)
CA (1) CA918071A (es)
DE (1) DE1924304C3 (es)
ES (1) ES379642A1 (es)
FR (1) FR2051519B1 (es)
GB (1) GB1256457A (es)
NL (1) NL169031B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7901565L (sv) * 1979-02-21 1980-08-22 Pharmacia Ab Medel for immunisering
US4358438A (en) * 1979-07-17 1982-11-09 Gist-Brocades N.V. Novel polyvalent virus vaccine against rabies and canine distemper
GB2053679A (en) * 1979-07-17 1981-02-11 Gist Brocades Nv Rabies/canine distemper vaccines
US5110794A (en) * 1987-01-30 1992-05-05 Abbott Laboratories Method of immunization with partially cationized substances and said partially cationized substances
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
AUPP807399A0 (en) * 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
DE10141748A1 (de) * 2001-08-29 2003-06-26 Janastyle Gmbh Schutzvorrichtung
EP1784210A2 (en) * 2004-08-04 2007-05-16 Cytos Biotechnology AG Carrier conjugates of gnrh-peptides
CN109663126A (zh) * 2019-03-01 2019-04-23 龙阔（苏州）生物工程有限公司 一种疫苗佐剂及其应用及猪繁殖与呼吸综合征疫苗
CN112516325B (zh) * 2019-09-18 2023-12-08 洛阳赛威生物科技有限公司 一种稳定的口蹄疫疫苗组合物及其应用

Also Published As

Publication number Publication date
FR2051519B1 (es) 1974-04-12
DE1924304B2 (de) 1979-10-25
JPS4921049B1 (es) 1974-05-29
DE1924304A1 (de) 1970-12-17
DE1924304C3 (de) 1980-07-17
BE750349A (fr) 1970-11-13
NL7006934A (es) 1970-11-17
CA918071A (en) 1973-01-02
US3632741A (en) 1972-01-04
GB1256457A (en) 1971-12-08
FR2051519A1 (es) 1971-04-09
NL169031B (nl) 1982-01-04

Similar Documents

Publication Publication Date Title
KR950701822A (ko) 간염B 표면 항원 및 다른 항원으로 구성된 조합 백신(Combined vaccines comprising hepatitis B surface antigen and other antines)
JP2015512448A5 (es)
AR041880A1 (es) Composicion inmunogena
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
EP0129923B1 (en) Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained
DK1149589T3 (da) Proteinadjuvanser
ES379642A1 (es) Procedimiento para la obtencion de vacunas perfeccionadas.
JP2015531389A5 (es)
GB1256456A (en) Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations
GB1441098A (en) Biological preparations
GB1292803A (en) Improvements relating to the production of antigens
WO2016130569A4 (en) A composition comprising pedv antigens and methods for making and using the composition
US9700615B2 (en) Adjuvant formulations and methods
WO2021202599A3 (en) Adeno-associated virus based compositions and related methods for inducing humoral immunity
WO2015082465A1 (en) Swine vaccine against prrs and lawsonia intracellularis
Eickhoff et al. Protection against Hong Kong influenza by adjuvant vaccine containing A2/Ann Arbor/67
US3579633A (en) Multiple closteridial antigen vaccine for animals
Green Cytotoxic property of mouse cancer antiserum.
US3479430A (en) Indirect passive immunization against transmissible gastroenteritis virus in nursing piglets at birth by active immunization of sows prior to farrowing with transmissible gastroenteritis vaccine and method of producing the same
CN106267183B (zh) 含有佐剂的活疫苗组合物及其制备方法和应用
Theodoridis et al. Studies on the development of a vaccine against bovine ephemeral fever
US3629413A (en) Polyvalent bovine vaccines and methods of making and using same
MX2022004869A (es) Vacuna de particulas similares al virus chikungunya y metodos de uso de la misma.
RU2111011C1 (ru) Вакцина "тривак (виэв)" для профилактики инфекционного ринотрахеита, парагриппа-3 и вирусной диареи - болезни слизистых крупного рогатого скота
Geddes et al. Chloramphenicol resistance in the typhoid bacillus.